373 related articles for article (PubMed ID: 12008951)
21. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
Niedbala MJ; Sartorelli AC
Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
[TBL] [Abstract][Full Text] [Related]
22. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
[TBL] [Abstract][Full Text] [Related]
23. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
24. Influence of exogenous growth factors on the expression of plasminogen activators and plasminogen activator inhibitors by cells isolated from normal and healing rabbit ligaments.
Murphy PG; Hart DA
J Orthop Res; 1994 Jul; 12(4):564-75. PubMed ID: 7520487
[TBL] [Abstract][Full Text] [Related]
25. Expression of mRNAs encoding insulin-like growth factor (IGF) ligands, IGF receptors and IGF binding proteins during follicular growth and atresia in the ovine ovary throughout the oestrous cycle.
Hastie PM; Haresign W
Anim Reprod Sci; 2006 May; 92(3-4):284-99. PubMed ID: 16023803
[TBL] [Abstract][Full Text] [Related]
26. The expression and function of IGFBP-3 in normal and malignant breast tissue.
McCarthy K; Laban C; McVittie CJ; Ogunkolade W; Khalaf S; Bustin S; Carpenter R; Jenkins PJ
Anticancer Res; 2009 Oct; 29(10):3785-90. PubMed ID: 19846909
[TBL] [Abstract][Full Text] [Related]
27. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer.
Nielsen BS; Sehested M; Timshel S; Pyke C; Danø K
Lab Invest; 1996 Jan; 74(1):168-77. PubMed ID: 8569179
[TBL] [Abstract][Full Text] [Related]
28. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8.
Rahimi F; Hsu K; Endoh Y; Geczy CL
FEBS J; 2005 Jun; 272(11):2811-27. PubMed ID: 15943814
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
[TBL] [Abstract][Full Text] [Related]
30. Coordinated regulation of the GH/IGF system genes during refeeding in rainbow trout (Oncorhynchus mykiss).
Gabillard JC; Kamangar BB; Montserrat N
J Endocrinol; 2006 Oct; 191(1):15-24. PubMed ID: 17065385
[TBL] [Abstract][Full Text] [Related]
31. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
32. mRNA expression of components of the insulin-like growth factor system in breast cancer cell lines, tissues, and metastatic breast cancer cells.
Gebauer G; Jäger W; Lang N
Anticancer Res; 1998; 18(2A):1191-5. PubMed ID: 9615787
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor.
Gualandris A; Presta M
J Cell Physiol; 1995 Mar; 162(3):400-9. PubMed ID: 7860647
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk.
Voskuil DW; Bosma A; Vrieling A; Rookus MA; van 't Veer LJ
Breast Cancer Res Treat; 2004 Apr; 84(3):225-33. PubMed ID: 15026620
[TBL] [Abstract][Full Text] [Related]
35. Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors.
Kitange G; Shibata S; Tokunaga Y; Yagi N; Yasunaga A; Kishikawa M; Naito S
Lab Invest; 1999 Apr; 79(4):407-16. PubMed ID: 10211993
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9.
Anteby EY; Greenfield C; Natanson-Yaron S; Goldman-Wohl D; Hamani Y; Khudyak V; Ariel I; Yagel S
Mol Hum Reprod; 2004 Apr; 10(4):229-35. PubMed ID: 14996996
[TBL] [Abstract][Full Text] [Related]
37. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast.
Hildenbrand R; Jansen C; Wolf G; Böhme B; Berger S; von Minckwitz G; Hörlin A; Kaufmann M; Stutte HJ
Lab Invest; 1998 Jan; 78(1):59-71. PubMed ID: 9461122
[TBL] [Abstract][Full Text] [Related]
39. Contrasting effects of transforming growth factor-beta and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts.
Hamilton JA; Wojta J; Gallichio M; McGrath K; Filonzi EL
J Immunol; 1993 Nov; 151(10):5154-61. PubMed ID: 8228215
[TBL] [Abstract][Full Text] [Related]
40. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]